UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women

Journal of bone and mineral research, 2004-04, Vol.19 (4), p.546-551

2004

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury

Circulation (New York, N.Y.), 2000-10, Vol.102 (16), p.2011-2018

2000

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Sjögren’s syndrome in a closed rural community

Annals of the rheumatic diseases, 1997-09, Vol.56 (9), p.521-525

1997

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Surrogate Markers of Clinical Outcome When Measured with Error

Biometrics, 1998-12, Vol.54 (4), p.1445-1462

1998

Link zum Volltext

Verfügbarkeit prüfen

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB11104 allele

Annals of the rheumatic diseases, 2000-05, Vol.59 (5), p.359-367

2000

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the severity of acute pancreatitis. the usefulness of ROC analysis in comparative studies of clinical and imaging prognostic indices

Journal of the Pancreas, 2006-03, Vol.7 (2), p.245-6; author reply 246-8

2006

Link zum Volltext

Verfügbarkeit prüfen

ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension

The American heart journal, 2000-11, Vol.140 (5), p.760-765

2000

Link zum Volltext

Verfügbarkeit prüfen

Algorithm for Statistical Detection of Peaks — Syndromic Surveillance System for the Athens 2004 Olympic Games

MMWR. Morbidity and mortality weekly report, 2004-09, Vol.53, p.86-94

2004

Link zum Volltext

Verfügbarkeit prüfen

Dental and periodontal status of Sjögren's syndrome

Journal of clinical periodontology, 2000-04, Vol.27 (4), p.231-235

2000

Link zum Volltext

Verfügbarkeit prüfen

Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome

Arthritis and rheumatism, 1999-08, Vol.42 (8), p.1765-1772

1999

Link zum Volltext

Verfügbarkeit prüfen

Malignant lymphoma in primary Sj gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj gren's syndrome

Arthritis and rheumatism, 1999-08, Vol.42 (8), p.1765-1772

1999

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment

Anticancer research, 1999-07, Vol.19 (4C), p.3543

1999

Link zum Volltext

Verfügbarkeit prüfen

A Method for Evaluating Surrogate Markers When Measured with Error Using the Cox Model

Therapeutic innovation & regulatory science, 1994, Vol.28 (3), p.667-690

1994

Link zum Volltext

Verfügbarkeit prüfen

Algorithm for statistical detection of peaks--syndromic surveillance system for the Athens 2004 Olympic Games

Morbidity and mortality weekly report. Supplement, 2004-09, Vol.53, p.86

2004

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

Cancer discovery, 2022-01, Vol.12 (1), p.108-133

2022

Link zum Volltext

Verfügbarkeit prüfen

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Oncotarget, 2016-04, Vol.7 (16), p.21247-21258

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

Annals of oncology, 2022-02, Vol.33 (2), p.181-192

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score

Journal of clinical oncology, 2019-02, Vol.37 (4), p.336-349

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon

The New England journal of medicine, 2006-02, Vol.354 (7), p.709-718

2006

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1647-1656

2020

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

ESMO open, 2023-06, Vol.8 (3), p.101566-101566, Article 101566

2023

Link zum Volltext

Verfügbarkeit prüfen

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

ESMO open, 2020-09, Vol.5 (5), p.e000681-e000681, Article e000681

2020

Link zum Volltext

Verfügbarkeit prüfen

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

ESMO open, 2020-09, Vol.5 (5), p.e000743-e000743, Article e000743

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(31)
Oncology
(23)
Female
(21)
Biological And Medical Sciences
(17)
Middle Aged
(17)
Adult
(16)
Male
(16)
Medical Sciences
(16)
Aged
(15)
Aged, 80 And Over
(6)
Prognosis
(6)
Retrospective Studies
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Chemotherapy
(5)
Follow-Up Studies
(5)
Original Research
(5)
Survival Analysis
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury

Prevalence of Sjögren’s syndrome in a closed rural community

Evaluating Surrogate Markers of Clinical Outcome When Measured with Error

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB11104 allele

Assessment of the severity of acute pancreatitis. the usefulness of ROC analysis in comparative studies of clinical and imaging prognostic indices

ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension

Algorithm for Statistical Detection of Peaks — Syndromic Surveillance System for the Athens 2004 Olympic Games

Dental and periodontal status of Sjögren's syndrome

Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome

Malignant lymphoma in primary Sj gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj gren's syndrome

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment

A Method for Evaluating Surrogate Markers When Measured with Error Using the Cox Model

Algorithm for statistical detection of peaks--syndromic surveillance system for the Athens 2004 Olympic Games

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score

Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon

A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

PB2707: ESMO‐MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO‐MCBS:H) VERSION 1.0

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

Suchergebnisse filtern